Avertto Medical

About

Headcount over time

Offices

Q&A

What is Avertto Medical's primary focus?

Avertto Medical is developing an AI-powered telemonitoring device for real-time stroke detection and prevention.

When was Avertto Medical founded?

Avertto Medical was founded in 2019.

What is Avertto Medical's primary sector?

Avertto Medical's primary sector is Digital Health.

How many employees did Avertto Medical have in August 2026?

In August 2026, Avertto Medical had 12 employees.

Which investors participated in Avertto Medical's Series A round in May 2024?

Avertto Medical's Series A round in May 2024 included investments from Cormorant Asset Management.

What was the amount of Avertto Medical's Series A funding round in May 2024?

Avertto Medical raised $30,500,000 in its Series A funding round in May 2024.

Which organizations provided a grant to Avertto Medical in June 2024?

In June 2024, Avertto Medical received a grant from the Israel Innovation Authority and the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

What is the latest grant Avertto Medical received?

In October 2025, Avertto Medical received a grant of $2,100,000 from the National Institutes of Health (NIH).

Who are the co-founders of Avertto Medical?

The co-founders of Avertto Medical are Hilla Ben-Pazi, Revital Shechter, and Avshalom Mizrahi.

Team · 10

Hilla Ben-Pazi

Founder · CEO & Co-Founder

Revital Shechter

Founder · Co-Founder

Avshalom Mizrahi

Founder · Co-Founder

Asher Kuper

CTO

Kety Bardugo

Chief Quality & Regulatory Officer

Yair Lavi

Algo team leader

Meron Ben Pazi

Product Manager

Lior Elmaliach

Clinical team

Yaniv Kirma

CTO

Alan Rotman

Chief Hardware & Software Architect

Sectors & technology